AHLA - Impact of Healthcare Reform on Managed Care Drug Benefits and Programs

The Patient Protection and Affordable Care Act of 2010 contains many provisions that impact health plans and other payors, PBMs, drug manufacturers, and individuals as it relates to managed care drug benefits and prescription drug pricing. This webinar will discuss some of the Act’s provisions with a focus on medication therapy management, creation of pathways for biosimilar biological products, expanded 340B drug program, average manufacturer price, Medicaid prescription drug rebates, and other drug-related issues.

Christine Rinn and Barbara Ryland are the presenters at this event.